These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29088513)

  • 1. Clinical and molecular effects of CHD7 in the heart.
    Corsten-Janssen N; Scambler PJ
    Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):487-495. PubMed ID: 29088513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital heart defects in CHARGE: The molecular role of CHD7 and effects on cardiac phenotype and clinical outcomes.
    Meisner JK; Martin DM
    Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):81-89. PubMed ID: 31833191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiac phenotype in patients with a CHD7 mutation.
    Corsten-Janssen N; Kerstjens-Frederikse WS; du Marchie Sarvaas GJ; Baardman ME; Bakker MK; Bergman JE; Hove HD; Heimdal KR; Rustad CF; Hennekam RC; Hofstra RM; Hoefsloot LH; Van Ravenswaaij-Arts CM; Kapusta L
    Circ Cardiovasc Genet; 2013 Jun; 6(3):248-54. PubMed ID: 23677905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHD7 mutations are not a major cause of atrioventricular septal and conotruncal heart defects.
    Corsten-Janssen N; du Marchie Sarvaas GJ; Kerstjens-Frederikse WS; Hoefsloot LH; van Beynum IM; Kapusta L; van Ravenswaaij-Arts CM
    Am J Med Genet A; 2014 Dec; 164A(12):3003-9. PubMed ID: 25257999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.
    Yan S; Thienthanasit R; Chen D; Engelen E; Brühl J; Crossman DK; Kesterson R; Wang Q; Bouazoune K; Jiao K
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28847-28858. PubMed ID: 33127760
    [No Abstract]   [Full Text] [Related]  

  • 6. Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation.
    Lalani SR; Safiullah AM; Fernbach SD; Harutyunyan KG; Thaller C; Peterson LE; McPherson JD; Gibbs RA; White LD; Hefner M; Davenport SL; Graham JM; Bacino CA; Glass NL; Towbin JA; Craigen WJ; Neish SR; Lin AE; Belmont JW
    Am J Hum Genet; 2006 Feb; 78(2):303-14. PubMed ID: 16400610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chd7 Is Critical for Early T-Cell Development and Thymus Organogenesis in Zebrafish.
    Liu ZZ; Wang ZL; Choi TI; Huang WT; Wang HT; Han YY; Zhu LY; Kim HT; Choi JH; Lee JS; Kim HG; Zhao J; Chen Y; Lu Z; Tian XL; Pan BX; Li BM; Kim CH; Xu HA
    Am J Pathol; 2018 Apr; 188(4):1043-1058. PubMed ID: 29353058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive endocrine phenotypes relating to CHD7 mutations in humans.
    Balasubramanian R; Crowley WF
    Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):507-515. PubMed ID: 29152903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype.
    Bergman JE; Janssen N; Hoefsloot LH; Jongmans MC; Hofstra RM; van Ravenswaaij-Arts CM
    J Med Genet; 2011 May; 48(5):334-42. PubMed ID: 21378379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants.
    Xu C; Cassatella D; van der Sloot AM; Quinton R; Hauschild M; De Geyter C; Flück C; Feller K; Bartholdi D; Nemeth A; Halperin I; Pekic Djurdjevic S; Maeder P; Papadakis G; Dwyer AA; Marino L; Favre L; Pignatelli D; Niederländer NJ; Acierno J; Pitteloud N
    Genet Med; 2018 Aug; 20(8):872-881. PubMed ID: 29144511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHARGEd with neural crest defects.
    Pauli S; Bajpai R; Borchers A
    Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):478-486. PubMed ID: 29082625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice.
    Randall V; McCue K; Roberts C; Kyriakopoulou V; Beddow S; Barrett AN; Vitelli F; Prescott K; Shaw-Smith C; Devriendt K; Bosman E; Steffes G; Steel KP; Simrick S; Basson MA; Illingworth E; Scambler PJ
    J Clin Invest; 2009 Nov; 119(11):3301-10. PubMed ID: 19855134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a novel CHD7 CHARGE syndrome variant by integrated omics analyses.
    Granadillo JL; Wegner DJ; Paul AJ; Willing M; Sisco K; Tedder ML; Sadikovic B; Wambach JA; Baldridge D; Cole FS;
    Am J Med Genet A; 2021 Feb; 185(2):544-548. PubMed ID: 33184947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sema3a plays a role in the pathogenesis of CHARGE syndrome.
    Ufartes R; Schwenty-Lara J; Freese L; Neuhofer C; Möller J; Wehner P; van Ravenswaaij-Arts CMA; Wong MTY; Schanze I; Tzschach A; Bartsch O; Borchers A; Pauli S
    Hum Mol Genet; 2018 Apr; 27(8):1343-1352. PubMed ID: 29432577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct cerebellar foliation anomalies in a CHD7 haploinsufficient mouse model of CHARGE syndrome.
    Whittaker DE; Kasah S; Donovan APA; Ellegood J; Riegman KLH; Volk HA; McGonnell I; Lerch JP; Basson MA
    Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):n/a. PubMed ID: 29168327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome.
    Zentner GE; Layman WS; Martin DM; Scacheri PC
    Am J Med Genet A; 2010 Mar; 152A(3):674-86. PubMed ID: 20186815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inner ear manifestations in CHARGE: Abnormalities, treatments, animal models, and progress toward treatments in auditory and vestibular structures.
    Choo DI; Tawfik KO; Martin DM; Raphael Y
    Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):439-449. PubMed ID: 29082607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHARGE syndrome-associated CHD7 acts at ISL1-regulated enhancers to modulate second heart field gene expression.
    Stathopoulou A; Wang P; Thellier C; Kelly RG; Zheng D; Scambler PJ
    Cardiovasc Res; 2023 Sep; 119(11):2089-2105. PubMed ID: 37052590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse Models for the Dissection of CHD7 Functions in Eye Development and the Molecular Basis for Ocular Defects in CHARGE Syndrome.
    Gage PJ; Hurd EA; Martin DM
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7923-30. PubMed ID: 26670829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria.
    Hale CL; Niederriter AN; Green GE; Martin DM
    Am J Med Genet A; 2016 Feb; 170A(2):344-354. PubMed ID: 26590800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.